hematopoietic stem cell transplantationpregnancy outcometransplantation conditioningneurologyBackground:Given the increasing numbers of multiple sclerosis (MS) patients undergoing autologous haematopoietic stem cell transplant (AHSCT) worldwide, and with women of childbearing age overrepresented i...
(2005). The lived experience post-autologous haematopoietic stem cell transplant (HSCT): A phenomenological study. European Journal of Oncology Nursing, 9, 204-215.Stephens M. The lived experience post-autologous haematopoietic stem cell transplant (HSCT): a phenomenological study. European Journal of...
Plasma cell proliferative index post-transplant is a powerful predictor of prognosis in myeloma patients failing to achieve a complete responseMyeloma patients failing to achieve a complete response post autologous stem cell transplantation are heterogeneous, some ultimately achieving deeper responses and ...
Cryptococcal meningitis following autologous stem cell transplant (SCT) has been described previously in only 1 patient, 4months post SCT and while off antifungal prophylaxis. We present a unique case of Cryptococcus meningitis pre-engraftment after autologous SCT, while the patient was receiving ...
6. Brody J, Wahlin BE, Phillips TJ, et al. Epcoritamab (epco) with gemcitabine+ oxaliplatin (GemOx) in patients (pts) with relapsed or refractory (R/R) diffuse large B-cell lymphoma (DLBCL) ineligible for autol...
Hepatic sinusoidal-obstruction syndrome and busulfan-induced lung injury in a post-autologous stem cell transplant recipientHepatic sinusoidal-obstruction syndrome and busulfan-induced lung injury in a post-autologous stem cell transplant recipientAutopsyHepatic...
The use of autologous stem cell transplantation is now investigated as an alternative to allotransplantation due to its lower risk of serious complications. However, autotransplantation is associated with a relatively high risk of post-transplant AML relapse that can be derived from contaminating ...
We report three cases of post-transplant lymphoproliferative disorder (PTLD) in the context of autologous stem cell transplantation (ASCT) for multiple myeloma (MM) and non-Hodgkin's lymphoma. The first two cases received ASCT for MM, one with a CD34-selected autograft and the other with an ...
Autologous stem cell transplantation (ASCT) is an important component of treatment of multiple myeloma (MM). The post-ASCT setting offers a unique opportunity to increase myeloma specific immunity through enhancement of T and NK cell responses. The vast array of therapeutics being developed for MM,...
The number needed to treat (NNT) with brentuximab vedotin consolidation therapy post-autologous stem cell transplant (ASCT) versus placebo in the phase 3 A... A Gautam,Y Zhu,E Ma,... - Leuk Lymphoma 被引量: 0发表: 2018年 Brentuximab vedotin and anti㏄D1 treatment optimize survival in ch...